Hou B, Fu Y, Weng C, Liu W, Zhao C, Yin Z. Homeostatic Plasticity Mediated by Rod-Cone Gap Junction Coupling in Retinal Degenerative Dystrophic RCS Rats. Front Cell Neurosci. 2017;11:98 pubmed publisher

Letra Vilela R, Sánchez Sánchez A, Rocha A, Martin V, Branco Santos J, Puente Moncada N, et al. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Mol Cell Endocrinol. 2016;434:238-49 pubmed publisher

Cecon E, Chen M, Marçola M, Fernandes P, Jockers R, Markus R. Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway. FASEB J. 2015;29:2566-82 pubmed publisher

Nishiyama K, Hirai K. The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 ?-cells. PLoS ONE. 2014;9:e102073 pubmed publisher

Chen C, Fichna J, Laudon M, Storr M. Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain. World J Gastroenterol. 2014;20:1298-304 pubmed publisher

Legros C, Devavry S, Caignard S, Tessier C, Delagrange P, Ouvry C, et al. Melatonin MT? and MT? receptors display different molecular pharmacologies only in the G-protein coupled state. Br J Pharmacol. 2014;171:186-201 pubmed publisher

Baba K, Benleulmi Chaachoua A, Journé A, Kamal M, Guillaume J, Dussaud S, et al. Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function. Sci Signal. 2013;6:ra89 pubmed publisher

Faria J, Kinote A, Ignacio Souza L, de Araújo T, Razolli D, Doneda D, et al. Melatonin acts through MT1/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats. Am J Physiol Endocrinol Metab. 2013;305:E230-42 pubmed publisher

Muxel S, Pires Lapa M, Monteiro A, Cecon E, Tamura E, Floeter Winter L, et al. NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS ONE. 2012;7:e52010 pubmed publisher

Kojima S, Tohei A, Ikeda M. Melatonin inhibits tachykinin NK? receptor-triggered 5-HT release from guinea pig isolated colonic mucosa. Br J Pharmacol. 2011;162:1179-85 pubmed publisher

Tunstall R, Shukla P, GRAZUL BILSKA A, Sun C, O Rourke S. MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries. J Pharmacol Exp Ther. 2011;336:127-33 pubmed publisher

Mickle A, Sood M, Zhang Z, Shahmohammadi G, Sengupta J, Miranda A. Antinociceptive effects of melatonin in a rat model of post-inflammatory visceral hyperalgesia: a centrally mediated process. Pain. 2010;149:555-64 pubmed publisher

Silva C, Tamura E, Macedo S, Cecon E, Bueno Alves L, Farsky S, et al. Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Br J Pharmacol. 2007;151:195-205 pubmed

Savinainen J, Kokkola T, Salo O, Poso A, Jarvinen T, Laitinen J. Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor. Br J Pharmacol. 2005;145:636-45 pubmed

Roy D, Angelini N, Fujieda H, Brown G, Belsham D. Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. Endocrinology. 2001;142:4711-20 pubmed

Sjöblom M, Jedstedt G, Flemstrom G. Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. J Clin Invest. 2001;108:625-33 pubmed